Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Shares Shorted: Short Interest Down 71.6% in October

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) was the target of a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 200 shares, a decrease of 71.6% from the September 30th total of 705 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 4,414 shares, the short-interest ratio is currently 0.0 days.

Santen Pharmaceutical Price Performance

OTCMKTS SNPHY remained flat at $11.19 during trading on Wednesday. 520 shares of the company’s stock traded hands. Santen Pharmaceutical has a twelve month low of $9.22 and a twelve month high of $13.93. The business’s 50-day moving average price is $11.20 and its two-hundred day moving average price is $11.49.

About Santen Pharmaceutical

Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription medicines and other products used to diagnose and treat eye diseases.

Its product portfolio includes ophthalmic treatments for conditions such as glaucoma, dry eye, allergic eye disease, ocular infections and retinal disorders. Santen also develops therapies for other vision-related conditions and provides products for eye-care professionals and patients.

Founded in 1890 and headquartered in Osaka, Japan, Santen serves patients and medical professionals through operations and commercial activities in Japan and international markets, including parts of Asia, Europe and other regions.